Pharmacokinetics of LCP-Tacro™ Once Daily and Prograf® Twice A Day in Adult De Novo Liver Transplant Patients

NCT00772148 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

58

Enrollment

INDUSTRY

Sponsor class

Conditions

Liver Failure

Interventions

DRUG: LCP -Tacro
DRUG: Prograf

Sponsor

Veloxis Pharmaceuticals

Collaborators

[object Object]
[object Object]